H.R. 1719House118th Congress (2023-2025)In Committee

Honoring Our Fallen Heroes Act of 2023

Introduced March 22, 2023

AI-Generated Summary

Updated January 20, 2026 at 5:06 AM UTC

The Honoring Our Fallen Heroes Act of 2023 amends the Omnibus Crime Control and Safe Streets Act of 1968 to give public safety officers who die or become permanently disabled from certain cancers linked to job exposures the same benefits as line‑of‑duty injuries. It defines “exposure‑related cancers,” creates a presumption of duty‑related injury when specific exposure and timing conditions are met, and lets the Director add new cancers after a petition. The changes apply to qualifying officers whose death or disability occurs on or after Jan 1 2023 and also updates related technical definitions.

Key Provisions

  • Adds a new “exposure‑related cancers” category with a list of specific cancers (e.g., bladder, lung, leukemia, mesothelioma, etc.) and allows the Bureau to add others later.
  • Presumes death or permanent total disability from an listed cancer is a line‑of‑duty injury if the officer was exposed to heat, radiation, or a carcinogen, began service within 5 years before diagnosis, was diagnosed within 15 years after leaving service, and the cancer caused the death/disability, unless medical evidence disproves the link.
  • Allows the Director of the Bureau to periodically review and add cancers to the list by rule, based on scientific evidence, and establishes a petition process with a 180‑day decision deadline and required notification to congressional judiciary committees.
  • Extends benefits to public safety officers who die or become permanently disabled from exposure‑related cancers on or after January 1 2023.
  • Updates the definition of “line of duty action” in the Safeguarding America’s First Responders Act of 2020 and removes a filing deadline restriction for claimants who qualify under the new provisions.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

2 earlier actions
HouseFloor Latest Action

ASSUMING FIRST SPONSORSHIP - Mr. Gimenez asked unanimous consent that he may hereafter be considered as the first sponsor of H.R. 1719, a bill originally introduced by Representative Pascrell, for the purpose of adding cosponsors and requesting reprintings pursuant to clause 7 of rule XII. Agreed to without objection.

September 25, 2024 • 5:53 PM

View full timeline
HouseIntro Referral

Introduced in House

March 22, 2023

HouseIntro Referral

Referred to the House Committee on the Judiciary.

March 22, 2023

HouseFloor

ASSUMING FIRST SPONSORSHIP - Mr. Gimenez asked unanimous consent that he may hereafter be considered as the first sponsor of H.R. 1719, a bill originally introduced by Representative Pascrell, for the purpose of adding cosponsors and requesting reprintings pursuant to clause 7 of rule XII. Agreed to without objection.

September 25, 2024 • 5:53 PM

Floor Debate

9 members

What members said about H.R. 1719 on the floor

6 Republicans3 Democrats
John H. Rutherford
Rep. John H. RutherfordR-FL-5 · May 15, 2023

Madam Speaker, I appreciate this time as we have our bipartisan Special Order hour to honor law enforcement officers all across America to talk about our back the blue. This evening, as we begin, I…

Don Bacon
Rep. Don BaconR-NE-2 · May 15, 2023

Madam Speaker, I thank Representative Rutherford for leading tonight's Special Order and being the expert on law enforcement issues. We came in together, and I look to the gentleman for doing the…

Bill Pascrell, Jr.
Rep. Bill Pascrell, Jr.D-NJ-9 · May 15, 2023

Madam Speaker, I associate myself with Mr. Rutherford's words. Madam Speaker, I am always proud to stand in support of our brave law enforcement officers, those officers who suit up every day. That…

Josh Gottheimer
Rep. Josh GottheimerD-NJ-5 · May 15, 2023

Madam Speaker, I thank Mr. Pascrell for his leadership in the caucus, supporting law enforcement, and always being there for those in New Jersey. I am very grateful. Madam Speaker, I thank Mr.…

Pete Stauber
Rep. Pete StauberR-MN-8 · May 15, 2023

Madam Speaker, I thank Chair Rutherford for putting on this hour. He served with honor. I thank him for continuing to lead in fighting for law enforcement in our Conference. Madam Speaker, I rise…

Show 4 more
Glenn Grothman
Rep. Glenn GrothmanR-WI-6 · May 15, 2023

Madam Speaker, we are here to commemorate another police week, and I think the average American never has an opportunity to see what the average policeman goes through and the risks they take.…

Norma J. Torres
Rep. Norma J. TorresD-CA-35 · May 15, 2023

Madam Speaker, as the mother of a Pomona police officer and former 911 dispatcher, I rise today to commemorate National Police Week. This week, we celebrate the heroes who don't make the headlines. I…

Bill Johnson
Rep. Bill JohnsonR-OH-6 · May 15, 2023

Madam Speaker, I thank my colleague for yielding to me. Service is something that is in my blood, and I can tell you that, as I rise today in support of the men and women who wear the blue as we…

Carlos A. Gimenez
Rep. Carlos A. GimenezR-FL-28 · Sep 25, 2024

Mr. Speaker, I ask unanimous consent that I may hereafter be considered to be the first sponsor of H.R. 1719, a bill originally introduced by Representative Pascrell of New Jersey, for the purpose of…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in HouseIssued March 22, 2023

I

118th CONGRESS

1st Session

H. R. 1719

IN THE HOUSE OF REPRESENTATIVES

March 22, 2023

Mr. Pascrell (for himself, Mr. Gimenez, Mr. Fitzpatrick, and Ms. Scanlon) introduced the following bill; which was referred to the Committee on the Judiciary

A BILL

To amend the Omnibus Crime Control and Safe Streets Act of 1968 to provide public safety officer benefits for exposure-related cancers, and for other purposes.

1.

Short title

This Act may be cited as the Honoring Our Fallen Heroes Act of 2023.

2.

Cancer-related deaths

(a)

In general

Section 1201 of title I of the Omnibus Crime Control and Safe Streets Act of 1968 (34 U.S.C. 10281) is amended by adding at the end the following:

(p)

Exposure-Related cancers

(1)

Definitions

In this subsection:

(A)

Carcinogen

The term carcinogen means a known or suspected carcinogen, as defined by the International Agency for Research on Cancer, that is reasonably linked to an exposure-related cancer.

(B)

Director

The term Director means the Director of the Bureau.

(C)

Exposure-related cancer

The term exposure-related cancer means—

(i)

bladder cancer;

(ii)

brain cancer;

(iii)

breast cancer;

(iv)

cervical cancer;

(v)

colon cancer;

(vi)

colorectal cancer;

(vii)

esophagus cancer;

(viii)

kidney cancer;

(ix)

leukemia;

(x)

lung cancer;

(xi)

malignant melanoma;

(xii)

mesothelioma;

(xiii)

multiple myeloma;

(xiv)

non-Hodgkins lymphoma;

(xv)

ovarian cancer;

(xvi)

prostate cancer;

(xvii)

skin cancer;

(xviii)

stomach cancer;

(xix)

testicular cancer;

(xx)

thyroid cancer;

(xxi)

any form of cancer that is considered a WTC-related health condition under section 3312(a) of the Public Health Service Act (42 U.S.C. 300mm–22(a)); and

(xxii)

any other form of cancer that the Bureau may determine appropriate in accordance with paragraph (3).

(2)

Personal injury sustained in the line of duty

(A)

In general

Subject to subparagraph (B), as determined by the Bureau, the death or permanent and total disability of a public safety officer due to an exposure-related cancer shall be presumed to constitute a personal injury within the meaning of subsection (a), sustained in the line of duty by the officer and directly and proximately resulting in death or permanent and total disability, if—

(i)

the public safety officer was exposed to or in contact with heat, radiation, or a carcinogen that is linked to an exposure-related cancer while in the course of the line of duty;

(ii)

the public safety officer began serving as a public safety officer not later than 5 years before the date of the diagnosis of the public safety officer with an exposure-related cancer;

(iii)

the public safety officer was diagnosed with an exposure-related cancer not later than 15 years after the last date of active service as a public safety officer of the public safety officer; and

(iv)

the exposure-related cancer directly and proximately results in the death or permanent and total disability of the public safety officer.

(B)

Exception

The presumption under subparagraph (A) shall not apply to the death or permanent and total disability of a public safety officer due to an exposure-related cancer if competent medical evidence establishes that the exposure-related cancer was unrelated to the exposure or contact described in subparagraph (A)(i).

(3)

Additional exposure-related cancers

(A)

In general

The Director shall—

(i)

periodically review the definition of exposure-related cancer under paragraph (1); and

(ii)

add a type of exposure-related cancer to the definition by rule, upon a showing by a petitioner or on the Director’s own determination, in accordance with this paragraph.

(B)

Basis for determination

The Director shall add a type of exposure-related cancer to the definition of exposure-related cancer under paragraph (1) upon a showing by a petitioner or the Director’s own determination, based on the weight of the best available scientific evidence, that there is a significant risk to public safety officers engaged in public safety activities of developing the type of exposure-related cancer.

(C)

Available expertise

In determining significant risk for the purpose of subparagraph (B), the Director may accept as authoritative and may rely upon recommendations, risk assessments, and scientific studies by the National Institute for Occupational Safety and Health, the National Toxicology Program, the National Academies of Sciences, Engineering, and Medicine, and the International Agency for Research on Cancer.

(D)

Petitions to add to the list of exposure-related cancers

(i)

In general

Any person may petition the Director to add a type of exposure-related cancer to the definition of exposure-related cancer under paragraph (1).

(ii)

Content of petition

A petition under clause (i) shall provide information to show that there is sufficient evidence, based on the weight of the best available scientific evidence, of significant risk to public safety officers engaged in public safety activities of developing such exposure-related cancer from their employment.

(iii)

Timely and substantive decisions

Not later than 180 days after receipt of a petition under this subparagraph, the Director shall grant or deny the petition by publishing in the Federal Register a written explanation of the reasons for the Director’s decision. The Director may not deny a petition solely on the basis of competing priorities, inadequate resources, or insufficient time for review.

(iv)

Notification to congress

Not later than 30 days after making any decision to approve or deny a petition under this subparagraph, the Director shall notify the Committee on the Judiciary of the Senate and the Committee on the Judiciary of the House of Representatives of the decision.

.

(b)

Applicability

The amendment made by subsection (a) shall apply in the case of any public safety officer who died or became permanently and totally disabled on or after January 1, 2023, as a result of an exposure-related cancer.

3.

Technical amendments

(a)

In general

Section 3 of the Safeguarding America’s First Responders Act of 2020 (34 U.S.C. 10281 note) is amended by adding at the end the following:

(d)

Definition

In this section, the term line of duty action includes any action in which a public safety officer engages at the direction of the agency served by the public safety officer.

.

(b)

Applicability

(1)

In general

The amendment made by subsection (a) shall apply in the case of any public safety officer who died on or after January 1, 2020.

(2)

Time for filing claim

Section 32.12(a)(1) of title 28, Code of Federal Regulations, shall not apply to a claimant who otherwise qualifies for support pursuant to the amendment made by subsection (a).